Seeking a new way to treat Parkinson's, Eli Lilly and Medtronic have agreed to work together on an approach that involves delivering a potential new medicine to the brain using an implantable drug delivery system. "By collaborating with Medtronic from the earliest phase of research, we are maximizing the potential for this therapy's efficient and effective development," said Michael Hutton, CSO of the neurodegeneration team at Lilly. News